Nisa Investment Advisors’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $109K | Buy |
3,832
+162
| +4% | +$4.6K | ﹤0.01% | 1367 |
|
2025
Q1 | $108K | Buy |
3,670
+239
| +7% | +$7.06K | ﹤0.01% | 1381 |
|
2024
Q4 | $99.8K | Sell |
3,431
-34
| -1% | -$989 | ﹤0.01% | 1472 |
|
2024
Q3 | $159K | Sell |
3,465
-934
| -21% | -$42.9K | ﹤0.01% | 1332 |
|
2024
Q2 | $180K | Buy |
4,399
+1,076
| +32% | +$44K | ﹤0.01% | 1334 |
|
2024
Q1 | $84.8K | Buy |
3,323
+123
| +4% | +$3.14K | ﹤0.01% | 1516 |
|
2023
Q4 | $29K | Buy |
3,200
+3,180
| +15,900% | +$28.8K | ﹤0.01% | 1765 |
|
2023
Q3 | $128 | Sell |
20
-1,878
| -99% | -$12K | ﹤0.01% | 2711 |
|
2023
Q2 | $21K | Buy |
1,898
+964
| +103% | +$10.7K | ﹤0.01% | 2082 |
|
2023
Q1 | $14K | Buy |
934
+910
| +3,792% | +$13.6K | ﹤0.01% | 2100 |
|
2022
Q4 | $1K | Sell |
24
-26
| -52% | -$1.08K | ﹤0.01% | 2496 |
|
2022
Q3 | $1K | Sell |
50
-188
| -79% | -$3.76K | ﹤0.01% | 2495 |
|
2022
Q2 | $3K | Hold |
238
| – | – | ﹤0.01% | 2328 |
|
2022
Q1 | $4K | Sell |
238
-1,920
| -89% | -$32.3K | ﹤0.01% | 2324 |
|
2021
Q4 | $36K | Buy |
2,158
+1,591
| +281% | +$26.5K | ﹤0.01% | 1810 |
|
2021
Q3 | $14 | Sell |
567
-4,600
| -89% | -$114 | ﹤0.01% | 2160 |
|
2021
Q2 | $128 | Hold |
5,167
| – | – | ﹤0.01% | 1578 |
|
2021
Q1 | $113 | Hold |
5,167
| – | – | ﹤0.01% | 1702 |
|
2020
Q4 | $132K | Buy |
+5,167
| New | +$132K | ﹤0.01% | 1623 |
|